Transcriptional targets shared by estrogen receptor‐related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ

The physiological activities of estrogens are thought to be mediated by specific nuclear receptors, ERα and ERβ. However, certain tissues, such as the bone, that are highly responsive to estrogens only express a low level of these receptors. Starting from this apparent contradiction, we have evaluated the potentials of two related receptors ERRα and ERRβ to intervene in estrogen signaling. ERα, ERRα and ERRβ bind to and activate transcription through both the classical estrogen response element (ERE) and the SF‐1 response element (SFRE). In contrast, ERβ DNA‐binding and transcriptional activity is restricted to the ERE. Accordingly, the osteopontin gene promoter is stimulated through SFRE sequences, by ERRα as well as by ERα, but not by ERβ. Analysis of the cross‐talk within the ER/ERR subgroup of nuclear receptors thus revealed common targets but also functional differences between the two ERs.

[1]  V. Laudet,et al.  Transcriptional Activities of the Orphan Nuclear Receptor ERRα (Estrogen Receptor-Related Receptor-α) , 1999 .

[2]  V. Laudet,et al.  Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). , 1999, Molecular endocrinology.

[3]  V. Laudet,et al.  Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  V. Laudet,et al.  Activation of the thyroid hormone receptor α gene promoter by the orphan nuclear receptor ERRα , 1998, Oncogene.

[5]  V. Giguère,et al.  Estrogen Receptor β: Re-evaluation of Estrogen and Antiestrogen Signaling , 1998, Steroids.

[6]  V. Giguère,et al.  Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. , 1998, Steroids.

[7]  C. Teng,et al.  The mouse estrogen receptor-related orphan receptor alpha 1: molecular cloning and estrogen responsiveness. , 1997, Journal of molecular endocrinology.

[8]  V. Laudet,et al.  Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. , 1997, Journal of molecular endocrinology.

[9]  Y. Onoe.  Expression of Estrogen Receptor in Rat Bone , 1997 .

[10]  S. Nozawa,et al.  Expression of Estrogen Receptor β in Rat Bone. , 1997, Endocrinology.

[11]  J. Gustafsson,et al.  Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. , 1997, Molecular endocrinology.

[12]  V. Laudet,et al.  Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development , 1997, Mechanisms of Development.

[13]  J. Aubin,et al.  The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. , 1997, Molecular endocrinology.

[14]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[15]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[16]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.

[17]  S. Nozawa,et al.  Expression of estrogen receptor beta in rat bone. , 1997, Endocrinology.

[18]  J. Gustafsson,et al.  Mouse Estrogen Receptor (cid:98) Forms Estrogen Response Element-Binding Heterodimers with Estrogen Receptor (cid:97) , 1997 .

[19]  J. Gustafsson,et al.  Orphan nuclear receptors--the first eight years. , 1996, Molecular endocrinology.

[20]  Roberto Pacifici,et al.  Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Elgort,et al.  Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence. , 1996, Molecular endocrinology.

[23]  A. Berkenstam,et al.  Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis , 1996, Mechanisms of Development.

[24]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[25]  B. Katzenellenbogen,et al.  Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. , 1995, Endocrinology.

[26]  A. Chambers,et al.  Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell , 1995, Molecular and cellular biology.

[27]  H. Gronemeyer,et al.  Transcription factors 3: nuclear receptors. , 1995, Protein profile.

[28]  K. Korach.  Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.

[29]  R T Turner,et al.  Skeletal effects of estrogen. , 1994, Endocrine reviews.

[30]  C. Glass.  Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. , 1994, Endocrine reviews.

[31]  D. Denhardt,et al.  Osteopontin: a protein with diverse functions , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Milbrandt,et al.  The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction , 1993, Molecular and cellular biology.

[33]  A. Craig,et al.  The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. , 1991, Gene.

[34]  H. DeLuca,et al.  Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Craig,et al.  Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. , 1989, The Journal of biological chemistry.

[36]  B. Komm,et al.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.

[37]  R. Evans,et al.  Identification of a new class of steroid hormone receptors , 1988, Nature.

[38]  K. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells. , 1988, Science.

[39]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[40]  J. Gustafsson,et al.  Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .